Trial Profile
The Influence of Timing of Cabergoline Initiation on Prevention of Ovarian Hyper Stimulation Syndrome in Patients Undergoing Intra Cytoplasmic Sperm Injection .
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 03 Apr 2020
Price :
$35
*
At a glance
- Drugs Cabergoline (Primary)
- Indications Ovarian hyperstimulation syndrome
- Focus Therapeutic Use
- 08 Apr 2018 Planned End Date changed from 1 Jun 2017 to 1 Apr 2019.
- 08 Apr 2018 Planned primary completion date changed from 1 Jun 2017 to 1 Dec 2018.
- 21 Feb 2017 Planned End Date changed from 1 Jul 2016 to 1 Jun 2017.